What Is the Difference Between Live and Non-Viable Cells?. Live and non-viable cells behave very differently in MSC therapy. Learn how cell viability shapes safety, signaling, and stem cell therapy outcomes. Learn
In MSC therapy, not every cell delivered to the body is biologically active. The proportion of live versus non-viable cells in a stem cell preparation is one of the most important quality measures in modern stem cell therapy.
A live cell has an intact membrane, functioning organelles, and the ability to respond to its environment. A non-viable cell has lost membrane integrity or metabolic activity and can no longer signal or differentiate.
Standard laboratory tests such as trypan blue exclusion or 7-AAD staining are used to count both populations before MSCs are released for clinical use.
Only live mesenchymal stem cells can release the growth factors, cytokines, and extracellular vesicles that drive the paracrine effects seen in stem cell therapy.
Non-viable cells contribute very little to these signals and may add cellular debris that the immune system must clear.
Most clinical-grade MSC preparations target >90% viability at the time of administration. Lower viability is a sign that handling, cryopreservation, or thawing was suboptimal. Clinics that share certificates of analysis make this number visible to patients.
Non-viable cells are not entirely inert. In large numbers they can trigger mild inflammatory responses as macrophages clear them. This is one reason why a high live-cell percentage is preferred over simply infusing more total cells.
Viability depends on the full chain of custody: GMP processing, cryoprotectant choice, controlled-rate freezing, validated thawing protocols, and short time-to-infusion. Each step is designed to preserve live MSC function before delivery.
Patients can request the post-thaw viability percentage, the cell counting method, and the time between thawing and administration.
Transparent providers will share this information as part of their quality process.
| Factor | Live Cells | Non-Viable Cells |
|---|---|---|
| Membrane | Intact | Damaged |
| Signaling | Active paracrine release | Minimal |
| Clinical effect | Drives MSC therapy outcomes | Limited |
| Quality target | >90% viability | Kept as low as possible |
Live cells drive the biological effects of MSC therapy, while non-viable cells contribute little and may add debris. Knowing the viability of your stem cell preparation is a basic patient right in modern stem cell therapy.
This article is for general informational and educational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before considering stem cell therapy.